vTv Therapeutics (VTVT) Total Non-Current Liabilities (2014 - 2022)

vTv Therapeutics has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $13.1 million for Q1 2022.

• In Q1 2022, Total Non-Current Liabilities rose 27.19% year-over-year to $13.1 million; the TTM figure through Mar 2022 stood at $13.1 million (up 27.19% YoY), while the FY2021 annual figure was $9.0 million, down 17.87% from the prior year.
• Total Non-Current Liabilities came in at $13.1 million for Q1 2022 at vTv Therapeutics, up from $9.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $43.2 million in Q2 2018 to a low of $8.3 million in Q3 2021.
• Average Total Non-Current Liabilities over 5 years is $19.9 million, with a median of $16.8 million recorded in 2020.
• Year-over-year, Total Non-Current Liabilities jumped 44.95% in 2018 and sank 49.82% in 2019.
• Over 5 years, Total Non-Current Liabilities stood at $28.7 million in 2018, then sank by 37.75% to $17.8 million in 2019, then slumped by 38.66% to $10.9 million in 2020, then slipped by 17.87% to $9.0 million in 2021, then surged by 46.17% to $13.1 million in 2022.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $13.1 million in Q1 2022, $9.0 million in Q4 2021, and $8.3 million in Q3 2021.